\n<\/p>\n
The popularity of glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and Wegovy, has significantly surged in recent years, with 1 in 8 Americans now using these drugs.1<\/span><\/sup>\u00a0Globally, around 20 million people rely on semaglutide, the active ingredient in these injections, to help with their weight loss goals.2<\/span><\/sup><\/p>\n But going down this shortcut to achieve your desired weight actually comes with long-lasting effects. While these drugs are often touted as a \u201cmiracle answer\u201d for shedding pounds, experts warn that taking them could cause you to lose more than just body fat \u2014 and expose you to dire, long-term consequences.<\/p>\n In an article published in the Daily Mail, Benjamin Bikman, Ph.D., a metabolic scientist at Brigham Young University in Utah, warns that GLP-1 receptor agonists are reshaping more than body weight \u2014 they\u2019re changing your physiology, psychology, and possibly your long-term health trajectory as well.3<\/span><\/sup><\/p>\n \u2022<\/span>Three major effects that Ozempic users aren\u2019t being told about \u2014<\/strong>\u00a0According to Bikman, Ozempic leads to long-term effects such as severe loss of muscle and bone, dulled emotional response that could lead to depression, and rapid rebound weight gain that leaves patients with a worse fat-to-muscle ratio than before.<\/p>\n \u2022<\/span>You lose not just fat, but lean muscle mass, too \u2014<\/strong>\u00a0The article notes one clinical trial on semaglutide, wherein 140 participants were tracked over 68 weeks and found that while they lost 23 pounds of fat, they also lost 15 pounds of lean muscle mass. That\u2019s nearly 40% of their total weight loss coming from tissue the body actually needs to survive and thrive.<\/p>\n \u2022<\/span>\u201cFrail people are much more likely to die young\u201d \u2014<\/strong>\u00a0Bikman notes that having low muscle mass and fragile bones especially among seniors, not only puts you at risk of injury from falls; it also weakens your immune system, compromising your body\u2019s ability to handle infections, which is also a common health concern among the elderly.<\/p>\n<\/div>\n Bikman says that people who use Ozempic and Wegovy are also losing their interest and desire for sexual intercourse and social enjoyment. \u201cThe benefit in reducing cravings for sweet food may actually be a reduction in cravings for life,\u201d he warns.4<\/span><\/sup>\u00a0But to make matters worse, Ozempic wreaks havoc on your mental state and leaves you feeling depressed.<\/p>\n \u2022<\/span>Semaglutide drugs are associated with an increased risk of depression \u2014<\/strong>\u00a0He highlights one study wherein semaglutide users developed a 195% increased risk of major depression and over 100% greater risk of suicidal behavior compared to those on other medications. According to the researchers:<\/p>\n \u201cThese findings underscore the critical need for physicians to thoroughly assess patient history before prescribing GLP-1 RAs and highlight the urgent requirement for further prospective clinical trials to fully understand the implications of GLP-1 RA use on mental health in the obese patient population.\u201d<\/em>5<\/span><\/sup><\/p>\n<\/blockquote>\n \u2022<\/span>Ozempic users are more prone to having suicidal thoughts \u2014<\/strong>\u00a0Bikman also notes additional findings from a World Health Organization (WHO) database that revealed a 45% higher rate of reported suicidal thoughts in patients using semaglutide, compared to the average across all medications.<\/p>\n \u2022<\/span>Why does Ozempic affect your mental state?<\/strong>\u00a0Basically, the drug\u2019s main component targets GLP-1 receptors \u2014 these are present not just in your digestive tract but also in critical brain areas. These regions, such as the lateral septum and hypothalamus, are essential for managing emotions, reward systems and appetite control.<\/p>\n \u2022<\/span>Particularly noteworthy is its influence on dopamine \u2014<\/strong>\u00a0This neurotransmitter is closely associated with mood regulation and reward perception. Research indicates that stimulating GLP-1 receptors enhances dopamine transporter expression, leading to decreased free dopamine levels in specific brain regions. This shift in dopamine signaling leads to alterations in your mood, motivation levels, and even how you experience pleasure.<\/p>\n \u2022<\/span>Government agencies insist there\u2019s \u201cno direct link\u201d \u2014<\/strong>\u00a0Although the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) later concluded there wasn\u2019t enough evidence to confirm a direct causal link, these early signals are hard to ignore.<\/p>\n<\/div>\n If you\u2019re using a drug that\u2019s not just flattening your appetite but also crushing your motivation and ability to enjoy life, you\u2019re likely to struggle more with personal growth, productivity, and maintaining social bonds \u2014 all of which are foundational to your mental health.<\/p>\n Lastly, Bikman says that using semaglutide drugs actually leads to more weight gain.6<\/span><\/sup>\u00a0He highlights a 2022 clinical trial involving roughly 200 long-term semaglutide users; most regained about two-thirds of their lost weight within a year after stopping the drug7<\/span><\/sup>\u00a0\u2014 this is what\u2019s called the Ozempic rebound.<\/p>\n \u2022<\/span>So why do you regain fat after stopping Ozempic?<\/strong>\u00a0Simply put, when you\u2019ve been taking Ozempic and suddenly stop, the hunger cues it had suppressed come raging back \u2014 this causes you to revert to unhealthy eating, which causes the weight to return.<\/p>\n To put it simply, the muscle and bone mass you lost while using this drug don\u2019t return naturally; however, fat comes back easily and quickly. Semaglutide also triggers the formation of new fat cells, according to Bikman.<\/p>\n \u201cThis becomes a problem because when a person start[s] to regain fat mass after stopping Ozempic, with more fat cells comes a greater potential to gain more fat. \u2018As a result, even though a person may still weight less than they did before starting the drug, they may be fatter, with a higher percentage of body fat,’\u201d<\/em>\u00a0he said.8<\/span><\/sup><\/p>\n<\/blockquote>\n \u2022<\/span>Other \u201chealth benefits\u201d also disappear when you stop using it \u2014<\/strong>\u00a0Ozempic is said to help reduce blood pressure, but this could bounce back when you discontinue using the drug. There\u2019s evidence that certain positive cardiometabolic effects persist; however, the gains are modest.<\/p>\n \u2022<\/span>Patients must be advised to stop the drug after a period of use \u2014<\/strong>\u00a0During this time, they must assess their cravings for carbohydrates. \u201cIdeally, a person has learned how to eat better and control carb cravings and their weight loss can be sustained in the long run,\u201d Bikman said.<\/p>\n<\/div>\n A separate report published in The Standard focused on another growing concern, one that hasn\u2019t received nearly enough attention \u2014 GLP-1 receptor agonists wreak havoc on your digestive health.9<\/span><\/sup><\/p>\n \u2022<\/span>Ozempic interferes with normal digestion (and not just in minor ways) \u2014<\/strong>\u00a0While nausea, vomiting, constipation, and diarrhea are the most commonly reported digestive side effects, these symptoms could snowball into dangerous, even life-altering complications, according to health experts.<\/p>\n \u2022<\/span>10% of GLP-1 drug users experience gastrointestinal disturbances \u2014<\/strong>\u00a0In some cases, these escalate into serious health concerns. Kiran Jones, a clinical pharmacist at Oxford Online Pharmacy, says the most worrying among them is stomach paralysis, or \u201cgastroparesis.\u201d This condition means food moves extremely slowly \u2014 or not at all \u2014 through the stomach. Left untreated, it causes persistent vomiting, malnutrition, and long-term digestive distress.<\/p>\n \u2022<\/span>GLP-1 receptor agonists intentionally slow digestion \u2014<\/strong>\u00a0This design aims to suppress your appetite and keep you feeling full longer. However, when overactivated, this same mechanism will throw your whole digestive system out of balance.<\/p>\n \u2022<\/span>Chronic digestive issues have a major impact on your mental health \u2014<\/strong>\u00a0Constant nausea, bloating, or pain disrupts your sleep, affects mood, and increases anxiety. Over time, your confidence in your body erodes.<\/p>\n \u2022<\/span>There are other rare but severe side effects linked to these drugs \u2014<\/strong>\u00a0Some users have experienced kidney damage, pancreatitis, and even thyroid cancer. Recently, I wrote an article about the many damaging effects linked to these medications, even though they only lead to \u201cmodest benefits.\u201d Read \u201cOzempic Linked to 19 Adverse Health Events<\/a>\u201d for more information.<\/p>\n<\/div>\n While The Standard article mentions remedies that will help curb the side effects of these drugs, like eating crackers or sipping mint tea 30 minutes after taking the medication, I believe the best strategy is to get off these drugs completely. There are better and more efficient ways to manage your weight without harming your mental and physical health.<\/p>\n From 2018 to 2024, the FDA Adverse Event Reporting System (FAERS), which tracks reports of adverse events related to drugs like Ozempic, recorded 62,000 adverse reactions to semaglutide and tirzepatide (used in brands like Mounjaro and Zepbound).10<\/span><\/sup><\/p>\n \u2022<\/span>Nearly 75% of the adverse events occurred after 2022 \u2014<\/strong>\u00a0Around 46,000 adverse event reports coincide with the increased availability and marketing of these drugs.<\/p>\n \u2022<\/span>FAERS has recorded 10,000 \u201cserious\u201d reactions to these drugs \u2014<\/strong>\u00a0These are events that result in hospitalization or life-threatening conditions. These aren\u2019t just minor inconveniences; they\u2019re significant medical events that could have long-lasting impacts on your health.<\/p>\n \u2022<\/span>There were also 162 reported deaths from these weight loss drugs \u2014<\/strong>\u00a0According to a Daily Mail article, the fatalities linked to these medications increased by 40% in just six months. For more information, read \u201cOzempic and Other Weight Loss Drugs Linked to 162 US Deaths<\/a>.\u201d<\/p>\n<\/div>\n In clinical trials, a staggering 80% to 90% of participants experienced at least one adverse event.11<\/span><\/sup>\u00a0Though most were mild to moderate, they led some people to discontinue the medication \u2014 which, if you\u2019re truly determined to be healthy, is the step in the right direction.<\/p>\n I believe the key to maintaining a healthy weight is optimizing your cellular energy production. This requires a multifaceted approach that takes effort to implement, but it leads to safer, healthier results \u2014 something GLP-1 receptor agonists don\u2019t offer. Here are five strategies that I recommend for healthy weight management.<\/p>\n 1.<\/span>Avoid Ozempic and other GLP-1 agonist receptors \u2014<\/strong>\u00a0These medications initially seem efficient in eliminating excess fat, however, their benefits are usually short-lived and, as mentioned above, the side effects (many of which are still unknown) are damaging.<\/p>\nGLP-1 Receptor Agonists Alter More Than Your Waistline<\/h4>\n
Ozempic Wrecks Your Mental Health<\/h4>\n
\n
The Ozempic \u2018Rebound\u2019 Problem<\/h4>\n
\n
Stomach Paralysis and Other Digestive Dangers Linger Under the Surface<\/h4>\n
Ozempic-Related Deaths and Adverse Reactions Are on the Rise<\/h4>\n
5 Strategies to Address Underlying Metabolic Challenges<\/h4>\n